Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Biovotec AS
AS
Active
Org 913037790
Haakon Viis Gate 5, 0161
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2014 · 12 years old
1 employees
www.biovotec.com
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Biovotec AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
11M
8M
6M
3M
0M
2020: 7M
7M
2020
2021: 2M (-71% vs 2020)
2M
-71%
2021
2022: 9M (+350% vs 2021)
9M
+350%
2022
2023: 1M (-89% vs 2022)
1M
-89%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
EBITDA
NOK millions
0M
-5M
-11M
-16M
-21M
2020: -8M
-8M
2020
2021: -11M (-37% vs 2020)
-11M
-37%
2021
2022: 0M (+100% vs 2021)
0M
2022
2023: -17M
-17M
2023
2024: -13M (+24% vs 2023)
-13M
+24%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
0
1 448
9 026
2 006
6 872
Staff expenses
−0
−0
−1 011
−1 799
−2 352
EBITDA
−12 872
−17 154
−466
−10 645
−8 460
Depreciation & amort.
−103
−103
−103
−103
−103
EBIT
−12 976
−17 258
−569
−10 748
−8 563
Net financials
1 624
866
419
−605
1 463
Profit before tax
−11 352
−16 392
−150
−11 353
−7 100
Tax
−0
−0
−0
−0
−0
Net profit
−11 352
−16 392
−150
−11 353
−7 100
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
13 903
26 068
20 565
34 465
42 220
Equity
11 437
22 789
18 947
19 097
30 450
Long-term debt
0
0
0
0
0
Short-term debt
2 467
3 279
1 618
15 368
11 770
Total debt
2 467
3 279
1 618
15 368
11 770
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2024
Equity ratio
82,3 %
This company
38,2 %
Market median
This company
Market median
115% above market
2020
2024
Return on equity
−99,3 %
This company
18,4 %
Market median
This company
Market median
640% below market
2020
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2020
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2020
2024
Debt / equity
0,22×
This company
0,62×
Market median
This company
Market median
65% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Biovotec AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
